On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials

Read full text Summarise with VIRAT
Authors: Peng Yang, Li Wang, Ying Yuan
Cited by: 0
References: 17

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Recently, the U.S. Food and Drug Administration (FDA) released draft guidance \citep{FDA2026} signaling a paradigm shift that facilitates the use of Bayesian methodology as the primary analysis and decision framework for drug approval. The cornerstone and fundamental challenge of this framework is the specification and calibration of Bayesian success criteria to control decision errors, ensuring reliable clinical and regulatory outcomes. In this work, we systematically investigate various Bayesian decision-error metrics, their theoretical interrelationships, and their alignment with conventional Frequentist counterparts. This investigation provides critical theoretical insights and practical guidance on calibrating Bayesian success criteria and operating characteristics to ensure robust decision-making and the integrity of public health decisions. We illustrate this framework using a clinical trial evaluating revascularization strategies for cardiogenic shock. A Shiny application will be available at www.trialdesign.org to assist sponsors and regulators in evaluating calibration strategies consistent with recent regulatory perspectives.

Fields of Study & Subjects

Statistical Methods in Clinical Trials Statistical Methods and Bayesian Inference Probability and Statistical Research

Publication details

Journal / source
arXiv (Cornell University)
Publication date
20 March 2026
Language
EN
Document type
Preprint